Post-Chemotherapy Changes and Agreement of CT-Derived Body Composition at L3 and T12 in Older Patients with Metastatic Colorectal Cancer: Associations with Nutritional Indices and Outcomes
Nutrients · 2026
DOI: 10.3390/nu18071090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Anıl Yıldız und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Başaksehir Çam ve Sakura City Hospital, 34480 İstanbul, Türkiye. Hauptthemen laut MEDLINE: Body Composition, Colorectal Neoplasms, Tomography, X-Ray Computed, Nutrition Assessment. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Age- and cancer-related sarcopenia and malnutrition are common in older patients with colorectal cancer (CRC) and may negatively influence treatment tolerance and prognosis. However, the comparative prognostic value of post-chemotherapy changes in CT-based body composition parameters at the third lumbar vertebra (L3) and the twelfth thoracic vertebra (T12) levels, and their associations with nutritional indices, remain unclear. This study aimed to examine and compare the prognostic relevance of post-chemotherapy body composition changes at L3 and T12 and to assess their relationship with nutritional indices in older patients with metastatic CRC (mCRC).
Methods
This retrospective study included 87 older patients with mCRC. Baseline and ~3-month follow-up CT scans were analyzed at L3 and T12 using 3D Slicer to quantify skeletal muscle index (SMI), subcutaneous adipose tissue index (SATI), visceral adipose tissue index (VATI), visceral-to-subcutaneous fat ratio (VSR), and intramuscular adipose tissue index (IMATI). Changes (Δ) in CT-derived body composition after chemotherapy were calculated as percentage change using ((follow-up − baseline)/baseline) × 100. Prognostic Nutritional Index (PNI) and Geriatric Nutritional Index (GNRI), which are established nutritional assessment tools, were calculated from baseline laboratory/anthropometric data. Agreement between T12 and L3 was assessed, and associations with grade ≥ 3 toxicity, progression-free survival (PFS), and overall survival (OS) were evaluated using multivariable models and ROC analyses.
Results
Mean age was 69.0 ± 4.5 years (59 male/28 female), and 26.4% developed grade ≥ 3 adverse events. Over 3 months, mean SMI declined significantly at both L3 (46.7 ± 8.8 → 42.8 ± 9.8 cm2/m2) and T12 (34.6 ± 8.2 → 31.6 ± 8.1 cm2/m2) (p < 0.001 for both), accompanied by decreases in VATI and VSR; T12-IMATI increased significantly. Baseline PNI showed a weak positive correlation with L3-SMI (r = 0.302, p = 0.033), whereas GNRI showed moderate correlations with SMI at L3 (r = 0.502, p < 0.001) and T12 (r = 0.317, p = 0.025) and was associated with longitudinal changes in muscle metrics. T12-SMI consistently yielded lower values than L3-SMI, and agreement varied by compartment (best for SATI; weakest for VSR). Lower GNRI and greater L3-SMI loss were independently associated with grade ≥ 3 toxicity; ΔL3-SMI showed the highest discrimination (AUC = 0.79, 95% CI = 0.69–0.87, p < 0.001; cut-off >5.1% loss). All patients progressed (median PFS 7.6 months); mortality was 82.8% (median follow-up: 25 months). In multivariable analysis, PFS, CRP, GNRI, and ΔL3-SMI remained independently associated with OS. ΔL3-SMI provided the strongest mortality discrimination (AUC = 0.85, 95% CI = 0.74–0.94, p < 0.001; cut-off >10.4% loss), while ΔIMATI was also informative (AUC = 0.71, 95% CI = 0.59–0.82, p = 0.023).
Conclusions
In older patients with mCRC, early post-chemotherapy skeletal muscle loss—particularly at the L3 level—showed the strongest prognostic association with severe toxicity and mortality. GNRI provided complementary prognostic information as a marker of baseline immunonutritional reserve. Although T12-derived measurements were correlated with L3-derived values, systematic bias suggests that they should not be interpreted interchangeably for longitudinal risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Başaksehir Çam ve Sakura City Hospital, 34480 İstanbul, Türkiye.
- Department of Medical Oncology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.
- Department of Medical Oncology, Bağcılar Research and Education Hospital, 34212 İstanbul, Türkiye.
- Department of Internal Medicine, Division of Geriatrics, Istanbul Medical Faculty, Istanbul University, 34320 İstanbul, Türkiye.
- Department of Radiology, Istanbul University Oncology Institute, 34093 İstanbul, Türkiye.
ORCID-Profile: Anıl Yıldız, Melin Aydan Ahmed, Abdulmunir Azizy, Simay Çokgezer, Ozan Deniz Aygörmez, Mustafa Durmaz, Mehmet Akif Karan
Zitieren
APA
Yıldız, A., Ahmed, M. A., Eren, N. N., Azizy, A., Artan, S., Çokgezer, S., Ulufer, B., Aygörmez, O. D., Karaoğlan, G., Tırnova, Ş. Z. Ş., Bahat, G., Durmaz, M., Yırgın, İ. K., Karabulut, S., Sakar, B., Karan, M. A., & Taştekin, D. (2026). Post-Chemotherapy Changes and Agreement of CT-Derived Body Composition at L3 and T12 in Older Patients with Metastatic Colorectal Cancer: Associations with Nutritional Indices and Outcomes. Nutrients. https://doi.org/10.3390/nu18071090
Vancouver
Yıldız A, Ahmed MA, Eren NN, Azizy A, Artan S, Çokgezer S, et al. Post-Chemotherapy Changes and Agreement of CT-Derived Body Composition at L3 and T12 in Older Patients with Metastatic Colorectal Cancer: Associations with Nutritional Indices and Outcomes. Nutrients. 2026. doi:10.3390/nu18071090
BibTeX
@article{Yldz2026,
author = {Yıldız, Anıl and Ahmed, Melin Aydan and Eren, Nihan Nizam and Azizy, Abdulmunir and Artan, Selay and Çokgezer, Simay and Ulufer, Bedirhan and Aygörmez, Ozan Deniz and Karaoğlan, Gündüz and Tırnova, Şirin Zelal Şahin and Bahat, Gulistan and Durmaz, Mustafa and Yırgın, İnci Kızıldağ and Karabulut, Senem and Sakar, Burak and Karan, Mehmet Akif and Taştekin, Didem},
title = {Post-Chemotherapy Changes and Agreement of CT-Derived Body Composition at L3 and T12 in Older Patients with Metastatic Colorectal Cancer: Associations with Nutritional Indices and Outcomes},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18071090}
}
EUVIMED